The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy

Drug combination represents one of the most accredited strategies of cancer therapy able to improve drug efficacy and possibly overcome drug resistance. Among the agents used to complement conventional chemotherapy, carbonic anhydrase IX (CAIX) inhibitors appear as one of the most suitable, as marke...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreucci, Elena, Ruzzolini, Jessica, Peppicelli, Silvia, Bianchini, Francesca, Laurenzana, Anna, Carta, Fabrizio, Supuran, Claudiu T., Calorini, Lido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211231/
https://www.ncbi.nlm.nih.gov/pubmed/30362384
http://dx.doi.org/10.1080/14756366.2018.1532419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211231/
https://www.ncbi.nlm.nih.gov/pubmed/30362384
http://dx.doi.org/10.1080/14756366.2018.1532419

Ejemplares similares